About us
At RewiredBio, we're using artificial intelligence to design smart drugs with the aim of reducing off-target effects. We achieve this by combining proprietary techniques in synthetic biology and machine learning to gain finer control of protein folding. As a result, we are expanding the paradigms of drug design. Our first target is a pathway that is implicated in over 90% of Cancers. Stay tuned for our progress.
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- Sydney
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
Get directions
Sydney, AU